Artificial Intelligence and Biosecurity Issues
No source abstract was supplied.
Record details
Published: 16 July 2026
Source: US Congressional Research Service (EveryCRSReport)
Category: Policy
Topics: Biotech
Retrieved: 18 July 2026
Related evidence
These records share source-supplied organisations, an exact publisher byline, automatic topics or regions. The reason is shown on every link; related does not mean supporting, agreeing with or verifying this record.
Consultancy to develop and pilot test Artificial Intelligence (AI) Solutions for pandemic preparedness, biosafety, and biosecurity risk mitigation.
African Union · 16 July 2026
Medicare and Medicaid Programs; CY 2027 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies; Medicare Shared Savings Program Requirements; and Medicare Prescription Drug Inflation Rebate Program
US Federal Register · 16 July 2026
Request for Information; Clinical Laboratory Improvement Amendments of 1988 (CLIA) Regulations
US Federal Register · 16 July 2026
FTC Secures Major Settlement with Caremark, Resolving Antitrust Case Against Second Drug Middleman
US FTC Press Releases · 14 July 2026
Biotechnology: Applications, Challenges, and Policy Options for Engineered Microbes for Waste Cleanup
US GAO Reports · 14 July 2026
RA355416 - H0842 - ENHANCING PHARMACY COMMUNICATION SKILLS USING AI-POWERED VIRTUAL AVATARS: A PROOF-OF-CONCEPT
UK Contracts Finder — AI procurement · 31 December 2025
How to cite this record
ethics.ai (16 July 2026), “Artificial Intelligence and Biosecurity Issues,” evidence record 11427, https://ethics.ai/record/11427 (originally published by US Congressional Research Service (EveryCRSReport)).
Use and limitations
This page is a stable index and citation surface for a source record. ethics.ai did not author the underlying report and has not independently verified every claim. Automatic topics may be imperfect. For consequential use, quote and cite the original publisher.